Annual Drug Patent Expirations for OSMOLEX+ER
Osmolex Er is a drug marketed by Adamas Operations and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.
Drug patent litigation for OSMOLEX ER.
This drug has fifteen patent family members in nine countries.
The generic ingredient in OSMOLEX ER is amantadine hydrochloride. One supplier is listed for this compound. Additional details are available on the amantadine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
